Calendrier des promotions Alterity Therapeutics Limited
Calendrier avancé
Graphique simple
À propos de l'entreprise Alterity Therapeutics Limited
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson's disease. plus de détailsIPO date | 2002-09-05 |
---|---|
ISIN | US02155X1063 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | aud |
Сайт | https://alteritytherapeutics.com |
Цена ао | 1.45 |
Changement de prix par jour: | -0.2858% (3.149) |
---|---|
Changement de prix par semaine: | +42.73% (2.2) |
Changement de prix par mois: | +188.07% (1.09) |
Changement de prix sur 3 mois: | +136.98% (1.325) |
Changement de prix sur six mois: | +73% (1.815) |
Changement de prix par an: | +26.1% (2.49) |
Evolution du prix sur 3 ans: | +256.01% (0.882) |
Evolution du prix sur 5 ans: | +204.85% (1.03) |
Evolution des prix sur 10 ans: | 0% (3.14) |
Evolution des prix depuis le début de l'année: | +163.87% (1.19) |
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
Établissements | Volume | Partager, % |
---|---|---|
Morgan Stanley | 51485 | 0.7 |
Bank of Montreal/Can/ | 14907 | 0.2 |
Twin Lakes Capital Management, LLC | 5925 | 0.08 |
Providence Capital Advisors, LLC | 200 | 0 |
Coppell Advisory Solutions, LLC | 149 | 0 |
Osaic Holdings Inc | 81 | 0 |
Sugarloaf Wealth Management, LLC | 33 | 0 |
Steward Partners Investment Advisory, LLC | 6 | 0 |
Superviseur | Titre d'emploi | Paiement | Année de naissance |
---|---|---|---|
Mr. Geoffrey Paul Kempler B.Sc. | Co-Founder & Non-Executive Chairman | 207.52k | 1955 (70 années) |
Dr. David A. Stamler M.D. | Chief Executive Officer | 613.33k | 1961 (64 année) |
Dr. Rudolph Emile Tanzi Ph.D. | Chief Scientific Advisor and Member of Research & Development Advisory Board | N/A | 1959 (66 années) |
Dr. Robert Cherny | Head of Research | N/A | |
Mr. Phillip Allen Hains BBus(Acc), C.A., M.B.A. | CFO & Company Secretary | N/A | 1959 (66 années) |
Dr. Steven D. Targum M.D. | Chief Medical Advisor |
Adresse: Australia, Melbourne, 350 Collins Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://alteritytherapeutics.com
Site web: https://alteritytherapeutics.com